人类免疫缺陷病毒2型衣壳的单个氨基酸在食蟹猴和人类TRIM5α存在的情况下会影响其复制。
A single amino acid of the human immunodeficiency virus type 2 capsid affects its replication in the presence of cynomolgus monkey and human TRIM5alphas.
作者信息
Song Haihan, Nakayama Emi E, Yokoyama Masaru, Sato Hironori, Levy Jay A, Shioda Tatsuo
机构信息
Department of Viral Infections, Research Institute for Microbial Diseases, Osaka University, 3-1 Yamada-Oka, Suita, Osaka 565-0871, Japan.
出版信息
J Virol. 2007 Jul;81(13):7280-5. doi: 10.1128/JVI.00406-07. Epub 2007 May 2.
Abstract
Human immunodeficiency virus type 2 (HIV-2) strains vary widely in their abilities to grow in Old World monkey (OWM) cells such as those of cynomolgus monkeys (CM). We evaluated eight HIV-2 isolates for their sensitivities to CM TRIM5alpha, an anti-HIV factor in OWM cells. We found that different HIV-2 isolates showed differences in their sensitivities to CM TRIM5alpha. Sequence analysis showed that TRIM5alpha-sensitive viruses had proline at the 120th position of the capsid protein (CA), whereas TRIM5alpha-resistant viruses had either alanine or glutamine. Mutagenesis studies indicated that the single amino acid at the 120th position indeed affected the sensitivity of the virus to CM TRIM5alpha.
摘要
2型人类免疫缺陷病毒（HIV-2）毒株在旧世界猴（OWM）细胞（如食蟹猴（CM）细胞）中的生长能力差异很大。我们评估了8株HIV-2分离株对CM TRIM5α（一种OWM细胞中的抗HIV因子）的敏感性。我们发现不同的HIV-2分离株对CM TRIM5α的敏感性存在差异。序列分析表明，对TRIM5α敏感的病毒在衣壳蛋白（CA）的第120位有脯氨酸，而对TRIM5α耐药的病毒在该位置则为丙氨酸或谷氨酰胺。诱变研究表明，第120位的单个氨基酸确实影响了病毒对CM TRIM5α的敏感性。
相似文献
1
A single amino acid of the human immunodeficiency virus type 2 capsid affects its replication in the presence of cynomolgus monkey and human TRIM5alphas.
J Virol. 2007 Jul;81(13):7280-5. doi: 10.1128/JVI.00406-07. Epub 2007 May 2.
2
Comparison of anti-viral activity of rhesus monkey and cynomolgus monkey TRIM5alphas against human immunodeficiency virus type 2 infection.
Virology. 2008 Apr 10;373(2):447-56. doi: 10.1016/j.virol.2007.12.022. Epub 2008 Feb 21.
3
A single amino acid of human immunodeficiency virus type 2 capsid protein affects conformation of two external loops and viral sensitivity to TRIM5α.
PLoS One. 2011;6(7):e22779. doi: 10.1371/journal.pone.0022779. Epub 2011 Jul 28.
4
Multiple sites in the N-terminal half of simian immunodeficiency virus capsid protein contribute to evasion from rhesus monkey TRIM5α-mediated restriction.
Retrovirology. 2010 Sep 8;7:72. doi: 10.1186/1742-4690-7-72.
5
Novel mutant human immunodeficiency virus type 1 strains with high degree of resistance to cynomolgus macaque TRIMCyp generated by random mutagenesis.
J Gen Virol. 2016 Apr;97(4):963-976. doi: 10.1099/jgv.0.000408. Epub 2016 Jan 20.
6
Fluorescent image analysis of HIV-1 and HIV-2 uncoating kinetics in the presence of old world monkey TRIM5α.
PLoS One. 2015 Mar 24;10(3):e0121199. doi: 10.1371/journal.pone.0121199. eCollection 2015.
7
A dominant-negative effect of cynomolgus monkey tripartite motif protein TRIM5alpha on anti-simian immunodeficiency virus SIVmac activity of an African green monkey orthologue.
Virology. 2006 Jun 20;350(1):158-63. doi: 10.1016/j.virol.2006.03.035. Epub 2006 May 2.
8
A single amino acid substitution of the human immunodeficiency virus type 1 capsid protein affects viral sensitivity to TRIM5 alpha.
Retrovirology. 2010 Jul 7;7:58. doi: 10.1186/1742-4690-7-58.
9
The effects of TRIM5α polymorphism on HIV-2ROD and SIVmac239 replication in PBMCs from Chinese rhesus macaques and Vietnamese-origin cynomolgus macaques.
Virology. 2016 Jan;487:222-9. doi: 10.1016/j.virol.2015.10.018. Epub 2015 Nov 6.
10
The carboxyl-terminus of human immunodeficiency virus type 2 circulating recombinant form 01_AB capsid protein affects sensitivity to human TRIM5α.
PLoS One. 2012;7(10):e47757. doi: 10.1371/journal.pone.0047757. Epub 2012 Oct 19.
引用本文的文献
1
The Confluence of HIV-1 and HIV-2: Implications for Disease Progression and Insights for Therapy.
Int J Microbiol. 2025 Jul 10;2025:3145677. doi: 10.1155/ijm/3145677. eCollection 2025.
2
Structural insights into HIV-2 CA lattice formation and FG-pocket binding revealed by single-particle cryo-EM.
Cell Rep. 2025 Feb 25;44(2):115245. doi: 10.1016/j.celrep.2025.115245. Epub 2025 Jan 25.
3
Intrahost evolution of the HIV-2 capsid correlates with progression to AIDS.
Virus Evol. 2022 Aug 24;8(2):veac075. doi: 10.1093/ve/veac075. eCollection 2022.
4
HIV-1 capsid variability: viral exploitation and evasion of capsid-binding molecules.
Retrovirology. 2021 Oct 26;18(1):32. doi: 10.1186/s12977-021-00577-x.
5
Hierarchical assembly governs TRIM5α recognition of HIV-1 and retroviral capsids.
Sci Adv. 2019 Nov 27;5(11):eaaw3631. doi: 10.1126/sciadv.aaw3631. eCollection 2019 Nov.
6
Multiple Pathways To Avoid Beta Interferon Sensitivity of HIV-1 by Mutations in Capsid.
J Virol. 2019 Nov 13;93(23). doi: 10.1128/JVI.00986-19. Print 2019 Dec 1.
7
Delayed disease progression in HIV-2: the importance of TRIM5α and the retroviral capsid.
Clin Exp Immunol. 2019 Jun;196(3):305-317. doi: 10.1111/cei.13280. Epub 2019 Mar 21.
8
Naturally Occurring Mutations in HIV-1 CRF01_AE Capsid Affect Viral Sensitivity to Restriction Factors.
AIDS Res Hum Retroviruses. 2018 Apr;34(4):382-392. doi: 10.1089/AID.2017.0212. Epub 2018 Feb 13.
9
Targeting TRIM5α in HIV Cure Strategies for the CRISPR-Cas9 Era.
Front Immunol. 2017 Nov 22;8:1616. doi: 10.3389/fimmu.2017.01616. eCollection 2017.
10
General Model for Retroviral Capsid Pattern Recognition by TRIM5 Proteins.
J Virol. 2018 Jan 30;92(4). doi: 10.1128/JVI.01563-17. Print 2018 Feb 15.
本文引用的文献
1
All three variable regions of the TRIM5alpha B30.2 domain can contribute to the specificity of retrovirus restriction.
J Virol. 2006 Sep;80(17):8554-65. doi: 10.1128/JVI.00688-06.
2
Lower levels of HIV RNA in semen in HIV-2 compared with HIV-1 infection: implications for differences in transmission.
AIDS. 2006 Apr 4;20(6):895-900. doi: 10.1097/01.aids.0000218554.59531.80.
3
Differential restriction of human immunodeficiency virus type 2 and simian immunodeficiency virus SIVmac by TRIM5alpha alleles.
J Virol. 2005 Sep;79(18):11580-7. doi: 10.1128/JVI.79.18.11580-11587.2005.
4
Human tripartite motif 5alpha domains responsible for retrovirus restriction activity and specificity.
J Virol. 2005 Jul;79(14):8969-78. doi: 10.1128/JVI.79.14.8969-8978.2005.
5
A specific region of 37 amino acid residues in the SPRY (B30.2) domain of African green monkey TRIM5alpha determines species-specific restriction of simian immunodeficiency virus SIVmac infection.
J Virol. 2005 Jul;79(14):8870-7. doi: 10.1128/JVI.79.14.8870-8877.2005.
6
HIV-1 proteases from drug-naive West African patients are differentially less susceptible to protease inhibitors.
Clin Infect Dis. 2005 Jul 15;41(2):243-51. doi: 10.1086/431197. Epub 2005 Jun 8.
7
Amino acid 36 in the human immunodeficiency virus type 1 gp41 ectodomain controls fusogenic activity: implications for the molecular mechanism of viral escape from a fusion inhibitor.
J Virol. 2005 May;79(10):5996-6004. doi: 10.1128/JVI.79.10.5996-6004.2005.
8
Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction.
J Virol. 2005 Mar;79(5):3139-45. doi: 10.1128/JVI.79.5.3139-3145.2005.
9
Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain.
Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2832-7. doi: 10.1073/pnas.0409853102. Epub 2005 Feb 2.
10
A single amino acid change in the SPRY domain of human Trim5alpha leads to HIV-1 restriction.
Curr Biol. 2005 Jan 11;15(1):73-8. doi: 10.1016/j.cub.2004.12.042.
Zotero 插件